The effectiveness of gabapentin and gabapentin/montelukast combination compared with dextromethorphan in the improvement of COVID-19- related cough: A randomized, controlled clinical trial.

Journal: The clinical respiratory journal

PMID: 35908849

INTRODUCTION: Cough is one of the most common presenting symptoms of COVID-19, which can persist for weeks or months.

Rasool Soltani

Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Sara Nasirharandi

Department of Infectious Diseases, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Farzin Khorvash

Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Maryam Nasirian

Department of Biostatistics and Epidemiology, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran.
Kian Dolatshahi

Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Atousa Hakamifard

Department of Infectious Diseases, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Acetates Cough COVID-19 COVID-19 Drug Treatment Cyclopropanes Dextromethorphan Gabapentin Humans Quinolines SARS-CoV-2 Sulfides Treatment Outcome

View on PubMed Access via DOI PubMed (35908849)